Target intelligence / Profile preview

Ribosomal protein L36 pseudogene 11 (RPL36P11)

Target: RPL36P11
Molecular classification: Other (processed pseudogene)

Overview

Ribosomal protein L36 pseudogene 11 (RPL36P11) is one of many processed pseudogenes derived from the gene encoding the ribosomal protein L36. Pseudogenes like RPL36P11 are DNA sequences resembling functional genes but have lost their protein-coding ability due to disabling mutations. They are scattered throughout the genome and do not encode functional proteins or play a direct role in biological processes, disease, or response to therapies[4][6][7]. RPL36P11 is not considered a therapeutic target, does not interact with drugs, and does not have a known molecular or disease function.

Other names: RPL36_1_620RPL36P11

Beyond the preview

Go deeper on Ribosomal protein L36 pseudogene 11 (RPL36P11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L36 pseudogene 11 (RPL36P11).

Explore the full profile